MANGOCEUTICALS, INC. — Form SCHEDULE 13D/A
Filed October 6, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Jacob D. Cohen filed an amended Schedule 13D/A regarding beneficial ownership of Mangoceuticals, Inc. (a $14.7M market-cap Texas health services company). The filing provides no specific details on share count, ownership percentage, transaction amount, or what changed from the prior Schedule 13D — only the bare administrative filing header is visible in this document extract.
Why this rating
Amendment filing alone is routine disclosure. No concrete details (shares, %, dollars, or substantive change) disclosed here; significance cannot be assessed without actual filing content.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.